RE:from today's posts
For me my negative speculation is based on the ever present hints of collaborations mentioned in MD&A. One would have to assume that with all of the attention in this sector that there must be some interest in SVA. That being said. Past behavior might indicate future behaviour...if that is true either the market or big pharma has labeled Sernova the ugly girl in the bar. After a few drinks and just before the bar closes someody will take her home cause she is an easy lay but no one wants their friends to know.